BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16697735)

  • 21. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
    Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
    Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of adiponectin on murine colitis induced by dextran sulfate sodium.
    Nishihara T; Matsuda M; Araki H; Oshima K; Kihara S; Funahashi T; Shimomura I
    Gastroenterology; 2006 Sep; 131(3):853-61. PubMed ID: 16952554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
    Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
    Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis.
    Cannarile L; Cuzzocrea S; Santucci L; Agostini M; Mazzon E; Esposito E; Muià C; Coppo M; Di Paola R; Riccardi C
    Gastroenterology; 2009 Feb; 136(2):530-41. PubMed ID: 18996377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.
    Sasaoka T; Ito M; Yamashita J; Nakajima K; Tanaka I; Narita M; Hara Y; Hada K; Takahashi M; Ohno Y; Matsuo T; Kaneshiro Y; Tanaka H; Kaneko K
    Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G568-76. PubMed ID: 21193526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.
    Ivory CP; Wallace LE; McCafferty DM; Sigalet DL
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1202-10. PubMed ID: 18845573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
    Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
    Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
    Srinivasan M; Summerlin DJ
    Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.
    Gonzalez-Rey E; Varela N; Sheibanie AF; Chorny A; Ganea D; Delgado M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4228-33. PubMed ID: 16537513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model.
    Oh K; Iimuro Y; Takeuchi M; Kaneda Y; Iwasaki T; Terada N; Matsumoto T; Nakanishi K; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G729-35. PubMed ID: 15550554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice.
    Xia Q; Pang W; Pan H; Zheng Y; Kang JS; Zhu SG
    Regul Pept; 2004 Nov; 122(3):173-8. PubMed ID: 15491788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.